MolNFT v1 · #142102 · protein
Sirb from bacillus subtilis with CO2+
5ZT7 · Sirohydrochlorin ferrochelatase: “Sirb from bacillus subtilis with CO2+”. X-ray diffraction, 1 ligand (CO), 6 pockets (best druggability 0.71). MolNFT v1 #142102 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5ZT7
- Type
- protein
- Length
- 506 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Sirohydrochlorin ferrochelatase
- EC
- 4.99.1.4
- UniProt
- O34632
- Ligands
- CO
- Pockets
- 6 · best druggability 0.71
Structure
x-ray diffraction · 2 distinct chains · 42% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Sirohydrochlorin ferrochelatase (EC 4.99.1.4) | protein | 254 | 42% helix, 19% strand | O34632 |
| B | Sirohydrochlorin ferrochelatase (EC 4.99.1.4) | protein | 252 | 42% helix, 18% strand | O34632 |
Ligands and binding sites
- CO · Cobalt (II) ion · metal · 9 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 337 | 0.71 | 0.83 | 30 | empty |
| 2 | 388 | 0.66 | 0.79 | 40 | empty |
| 3 | 260 | 0.53 | 0.76 | 40 | empty |
| 4 | 131 | 0.49 | 0.79 | 19 | empty |
| 5 | 82 | 0.36 | 0.76 | 13 | empty |
Interfaces
1 interface between chains.
- A–B · 557 Ų buried · 4 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O34632
- Elsewhere: RCSB PDB 5ZT7 · PDBe 5ZT7 · UniProt O34632
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.